Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 8, 2016, Pages 1055-1059

  Adjobimey, M ^a   Masserey, E ^b   Adjonou, C ^a   Gbenagnon G ^c   Schwoebel, V ^d   Anagonou, S ^a   Zellweger, J P ^e  

^a Centre National Hospitalier de Pneumo Phtisiologie   (Benin)

^b Service de la Santé publique   (Switzerland)

^c Centre Hospitalier de Pneumo Phtisiologie Akron   (Benin)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e Swiss Lung Association   (Switzerland)

Author keywords

Children; Preventive chemotherapy; TB; TB contacts

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ARTICLE; BENIN; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICATION COMPLIANCE; MIXED INFECTION; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TUBERCULOSIS CONTROL; WEIGHT GAIN; AGE; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG EFFECTS; EPIDEMIOLOGY; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PRIMARY PREVENTION; PROGRAM EVALUATION; RISK FACTOR; SPUTUM; TIME FACTOR; TRANSMISSION; TREATMENT OUTCOME;

AGE FACTORS; ANTITUBERCULAR AGENTS; BENIN; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; ISONIAZID; MALE; MEDICATION ADHERENCE; MYCOBACTERIUM TUBERCULOSIS; PRIMARY PREVENTION; PROGRAM EVALUATION; RISK FACTORS; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84978238188     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0493     Document Type: Article

References (19)

1. Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis: A critical review of literature from the pre-chemotherapy era. Int JTuberc Lung Dis 2004; 8: 278-285.
2. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: A critical review of literature from the pre-chemotherapy era. Int JTuberc Lung Dis 2004; 8: 392-402.
3. Chan PC, Shinn-Forng Peng S, Chiou MY, et al. Risk for tuberculosis in child contacts. Development and validation of a predictive score. Am JRespir Crit Care Med 2014; 189: 203-213.
4. Triasih R, Robertson C, Duke T, Graham SM. Risk of infection and disease with Mycobacterium tuberculosis among children identified through prospective community-based contact screening in Indonesia. Trop Med Int Health 2015; 20: 737-743.
5. Gomes VF, Andersen A, Wejse C, et al. Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau. Thorax 2011; 66: 163-167.
6. World Health Organization. Guidance for national tuberculosis programmes in the management of tuberculosis in children. 2nd ed. WHO/HTM/TB/2014.03. Geneva, Switzerland: WHO, 2014.
7. Graham SM. Desk-guide for diagnosis and management of TB in children. Paris, France: International Union Against Tuberculosis and Lung Disease, 2013.
8. World Health Organization. Guidelines on the management of latent tuberculosis infection. WHO/HTM/TB/2015.01. Geneva, Switzerland: WHO, 2015.
9. Mandalakas AM, Hesseling AC, Gie RP, Schaaf HS,Marais BJ, Sinanovic E. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 2013; 68: 247-255.
10. van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int JTuberc Lung Dis 2006; 10: 13-18.
11. Osman M, Hesseling AC, Beyers N, et al. Routine programmatic delivery of isoniazid preventive therapy to children in Cape Town, South Africa. Public Health Action 2013; 3: 199-203.
12. Gomes VF, Wejse C, Oliveira I, et al. Adherence to isoniazid preventive therapy in children exposed to tuberculosis: A prospective study from Guinea-Bissau. Int JTuberc Lung Dis 2011; 15: 1637-1643.
13. Gninafon M, Trébucq A, Rieder HL. Epidemiology of tuberculosis in Benin. Int JTuberc Lung Dis 2011; 15: 61-66.
14. World Health Organization. Global tuberculosis report, 2014. WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO, 2014.
15. Ade S, Harries AD, Trébucq A, et al. The burden and outcomes of childhood tuberculosis in Cotonou, Benin. Public Health Action 2013; 3: 15-19.
16. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int JTuberc Lung Dis 2004; 8: 636-647.
17. Trébucq A, Zellweger JP, Kassa F, Lambregts K, Gninafon M. Are the statistical data from Benin's National Tuberculosis Programme reliable? Int JTuberc Lung Dis 2010; 14: 434-439.
18. Jaganath D, Zalwango S, Okware B, et al. Contact investigation for active tuberculosis among child contacts in Uganda. Clin Infect Dis 2013; 57: 1685-1692.
19. Triasih R, Robertson CF, Duke T, Graham SM. Aprospective evaluation of the symptom-based screening approach to the management of children who are contacts of tuberculosis cases. Clin Infect Dis 2015; 60: 12-18.